No photo of Anna Kreutzman

Anna Kreutzman

  • PL 63 (Haartmaninkatu 8)

    00014

    Finland

20102019
If you made any changes in Pure these will be visible here soon.

Publications 2010 2019

Filter
Article
2019

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

Kreutzman, A., Yadav, B., Brummendorf, T. H., Gjertsen, B. T., Hee, M. L., Janssen, J., Kasanen, T., Koskenvesa, P., Lotfi, K., Markevärn, B., Olsson-Stromberg, U., Stentoft, J., Stenke, L., Söderlund, S., Udby, L., Richter, J., Hjörth-Hansen, H. & Mustjoki, S., 2 Sep 2019, In : OncoImmunology. 8, 9, 13 p., e1638210.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File
2018

Immune cell phenotype and functional defects in Netherton syndrome

Eränkö, E., Ilander, M., Tuomiranta, M., Mäkitie, A., Lassila, T., Kreutzman, A., Klemetti, P., Mustjoki, S., Hannula-Jouppi, K. & Ranki, A., 26 Nov 2018, In : Orphanet journal of rare diseases. 13, 10 p., 213.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File
2017

Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner

Kreutzman, A., Colom-Fernandez, B., Marcos Jimenez, A., Ilander, M., Cuesta-Mateos, C., Perez-Garcia, Y., Delgado Arevalo, C., Bruck, O., Hakanen, H., Saarela, J., Ortega-Carrion, A., de Rosendo, A., Juanes-Garcia, A., Luis Steegmann, J., Mustjoki, S., Vicente-Manzanares, M. & Munoz-Calleja, C., 1 Nov 2017, In : Clinical Cancer Research. 23, 21, p. 6697-6707 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia

Koskela, H. L. M., El Missiry, M., Ruusila, A., Koskenvesa, P., Bruemmendorf, T. H., Gjertsen, B. T., Janssen, J., Lotfi, K., Markevarn, B., Olsson-Stromberg, U., Stenke, L., Stentoft, J., Richter, J., Hjorth-Hansen, H., Kreutzman, A. & Mustjoki, S., Aug 2017, In : Journal of Cancer Research and Clinical Oncology. 143, 8, p. 1543-1554 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File
2014

Dasatinib promotes Th1-type responses in granzyme B expressing T-cells

Kreutzman, A., Ilander, M., Porkka, K., Vakkila, J. & Mustjoki, S., 1 May 2014, In : OncoImmunology. 3, e28925.

Research output: Contribution to journalArticleScientificpeer-review

Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-alpha Monotherapy

Ilander, M., Kreutzman, A., Rohon, P., Melo, T., Faber, E., Porkka, K., Vakkila, J. & Mustjoki, S., 31 Jan 2014, In : PLoS One. 9, 1, 11 p., 87794.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Imatinib and pegylated IFN-alpha 2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response

Koskenvesa, P., Kreutzman, A., Rohon, P., Pihlman, M., Vakkila, E., Rasanen, A., Vapaatalo, M., Remes, K., Lundan, T., Hjorth-Hansen, H., Vakkila, J., Simonsson, B., Mustjoki, S. & Porkka, K., May 2014, In : European Journal of Haematology. 92, 5, p. 413-420 8 p.

Research output: Contribution to journalArticleScientificpeer-review

2013

Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy

Mustjoki, S., Auvinen, K., Kreutzman, A., Rousselot, P., Hernesniemi, S., Melo, T., Lahesmaa-Korpinen, A-M., Hautaniemi, S., Bouchet, S., Molimard, M., Smykla, R., Lee, F. Y., Vakkila, J., Jalkanen, S., Salmi, M. & Porkka, K., Apr 2013, In : Leukemia. 27, 4, p. 914-924 11 p.

Research output: Contribution to journalArticleScientificpeer-review

2012

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

Kreutzman, A., Jaatinen, T., Greco, D., Vakkila, E., Richter, J., Ekblom, M., Hjorth-Hansen, H., Stenke, L., Melo, T., Paquette, R., Seggewiss-Bernhardt, R., Guerci-Bresler, A., Talbot, A., Cayuela, J. M., Mahon, F-X., Porkka, K., Lipton, J., Partanen, J., Rousselot, P. & Mustjoki, S., 1 Nov 2012, In : Experimental Hematology. 40, 11, p. 906-913 8 p.

Research output: Contribution to journalArticleScientificpeer-review

2011

Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-alpha Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

Kreutzman, A., Rohon, P., Faber, E., Indrak, K., Juvonen, V., Kairisto, V., Voglova, J., Sinisalo, M., Flochova, E., Vakkila, J., Arstila, P., Porkka, K. & Mustjoki, S., 2011, In : PLoS One. 6, 8, p. art. e23022 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Expansion of highly differentiated CD8(+) T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

Kreutzman, A., Ladell, K., Koechel, C., Gostick, E., Ekblom, M., Stenke, L., Melo, T., Einsele, H., Porkka, K., Price, D. A., Mustjoki, S. & Seggewiss, R., 2011, In : Leukemia. 25, p. 1587-1597 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Poor cytokine-induced phosphorylation in chronic myeloid leukemia patients at diagnosis is effectively reversed by tyrosine kinase inhibitor therapy

Jalkanen, S. E., Vakkila, J., Kreutzman, A., Nieminen, J. K., Porkka, K. & Mustjoki, S., 2011, In : Experimental Hematology. 39, 1, p. 102-113 12 p.

Research output: Contribution to journalArticleScientificpeer-review

2010

Interferon Alpha Treated Patients with Chronic Myeloid Leukemia (CML) In Prolonged Complete Remission Have Increased Numbers of NK-Cells and Clonal Gamma-Delta T-Cells, and a Distinct Plasma Cytokine Profile.

Kreutzman, A., Rohon, P., Faber, E., Indrak, K., Juvonen, V., Kairisto, V., Voglova, J., Sinisalo, M., Flochova, E., Arstila, P., Porkka, K. & Mustjoki, S., 2010, In : Blood. 116, p. 515-516 2 p.

Research output: Contribution to journalArticleScientificpeer-review

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy

Kreutzman, A., Juvonen, V., Kairisto, V., Ekblom, M., Stenke, L., Seggewiss, R., Porkka, K. & Mustjoki, S., 2010, In : Blood. 116, 5, p. 772-782 11 p.

Research output: Contribution to journalArticleScientificpeer-review